Rohtesh S. Mehta, MD, MPH, MS

Dr. Rohtesh Mehta is a hematologist and blood and marrow transplant (BMT) physician-scientist who treats patients with leukemia, myelodysplastic syndromes and graft-versus-host disease (GVHD), a complication of BMT where donor immune cells attack the recipient’s body. He finds the BMT field fascinating because it can potentially cure life-threatening illnesses, but it can also leave a recipient with debilitating lifelong complications such as GVHD. Although immense strides have been made in the prevention and treatment of GVHD, it remains one of the most common causes of mortality post-transplantation. His clinical and research focus is to study ways the risk of GVHD can be lowered through improved donor and graft selection during the transplant process. He is also interested in the treatment of acute and chronic GVHD. He has published many studies comparing different donor/graft sources through the Center for International Blood and Marrow Transplant Research registry as well as single-center analysis. He has also led prospective clinical trials for the prevention of GVHD and treatment of chronic GVHD.